Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
RPTH Journal shared on LinkedIn:
”How to manage VTE in patients with peripheral arterial disease
Patients with peripheral arterial disease routinely receive antithrombotic therapy, yet the optimal management of a VTE in this population remains uncertain.
Using nationwide Dutch data , this study highlights substantial variability in real-world practice and underscores the need for clear guidance and consensus in this complex clinical scenario.
Read the full article here.”
Article: Antithrombotic therapy in lower extremity peripheral artery disease patients with venous thromboembolism: a nationwide cohort study
Authors: Jamilla Goedegebuur, Elena Butera, Qingui Chen, Behnood Bikdeli, Walter Ageno, Roberto Pola, Angelo Porfidia, Stefano Barco, Thijs E. van Mens, Joost R. van der Vorst, Suzanne C. Cannegieter, Frederik
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC